Jonah Kaplan

Jonah Kaplan is a seasoned professional in the field of biopharmaceutical development with extensive experience in CMC (Chemistry, Manufacturing, and Controls) across multiple organizations. Currently serving as Senior Director of CMC Upstream & Discovery Process Development at Xilio Therapeutics, Inc. since March 2021, Jonah has held various roles in the company, including Director and Associate Director of CMC Development. Prior experience includes positions at Vertex Pharmaceuticals, Semma Therapeutics, and AbbVie, where Jonah provided technical and scientific support for biologics manufacturing processes and was involved in regulatory compliance. Educationally, Jonah earned a Ph.D. in Biomedical Engineering from Boston University, after completing a Bachelor's in Bioengineering at Lehigh University. Prior research contributions include advancements in drug delivery systems during a graduate assistantship at Boston University, collaborating with Brigham & Women's Hospital.